张志荣, 王建新, 吕剑. 中心组合设计法优化3′,5′-二辛酰基-氟苷药质体制备工艺J. 药学学报, 2001, 36(6): 456-461.
引用本文: 张志荣, 王建新, 吕剑. 中心组合设计法优化3′,5′-二辛酰基-氟苷药质体制备工艺J. 药学学报, 2001, 36(6): 456-461.
ZHANG Zhi-rong, WANG Jian-xin, LU Jian. OPTIMIZATION OF THE PREPARATION OF 3′,5′-DIOCTANOYL-5-FLUORO-2′-DEOXYURIDINE PHARMACOSOMES USING CENTRAL COMPOSITE DESIGNJ. Acta Pharmaceutica Sinica, 2001, 36(6): 456-461.
Citation: ZHANG Zhi-rong, WANG Jian-xin, LU Jian. OPTIMIZATION OF THE PREPARATION OF 3′,5′-DIOCTANOYL-5-FLUORO-2′-DEOXYURIDINE PHARMACOSOMES USING CENTRAL COMPOSITE DESIGNJ. Acta Pharmaceutica Sinica, 2001, 36(6): 456-461.

中心组合设计法优化3′,5′-二辛酰基-氟苷药质体制备工艺

OPTIMIZATION OF THE PREPARATION OF 3′,5′-DIOCTANOYL-5-FLUORO-2′-DEOXYURIDINE PHARMACOSOMES USING CENTRAL COMPOSITE DESIGN

  • 摘要: 目的采用中心组合设计法优化3′,5′-二辛酰基-5-氟脲嘧啶脱氧核苷药质体的制备工艺.方法以薄膜-超声分散法制备药质体,以平均粒径、包封率、载药量和综合指标为因变量,对药物与磷脂的比例、F-68浓度和三硬脂酸甘油酯浓度3个自变量的各个水平进行二项式拟合,效应面法选取较佳工艺条件并进行预测分析.结果平均粒径、包封率、载药量和综合指标拟合所得多元二次方程的复相关系数分别为0.9393,0.7739,0.9801和0.8369.优化条件制备的药质体的平均粒径、包封率和载药量分别为76nm,97.49%和29.37%.结论中心组合设计有应用简便、预测性好等优点,制备的药质体符合设计要求.

     

    Abstract: AIM To optimize the preparation of 3′,5′-dioctanoyl-5- fluoro-2′-deoxyuridine pharmacosomes (DO-FUdR-PS) by using central composite design. METHODS DO-FUdR-PS was prepared by a thin-layer ultrasonication technique. The effects of drug phosphatidycholine ratio, pluronic F-68 concentration (%, w/v) and glycerol tristearate (%, w/v) concentration on the mean particle size, entrapment ratio (ER) and drug loading (DL) were investigated. A second order polynomial equation was fitted to the data and the resulting model was used to predict the response in the optimal region. RESULTS All the investigated response variables were found to be highly dependent on the formulation variables. Under the optimized conditions, the mean particle size, ER and DL of DO-FUdR-PS were 76 nm, 97.49% and 31.44%, respectively, which highly agreed with the predicted values. CONCLUSION Central composite design was successfully used to optimize the preparation of DO-FUdR-PS.

     

/

返回文章
返回